SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery
Related Experiment Video
Updated: Aug 10, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Bahar Tercan1, Guangrong Qin1, Taek-Kyun Kim1
1Institute for Systems Biology, Seattle, WA, 98109, USA.
Abstract:
Synthetic lethal interactions (SLIs), genetic interactions in which the simultaneous inactivation of two genes leads to a lethal phenotype, are promising targets for therapeutic intervention in cancer, as exemplified by the recent success of PARP inhibitors in treating BRCA1/2-deficient tumors. We present SL-Cloud, a new component of the Institute for Systems Biology Cancer Gateway in the Cloud (ISB-CGC), that provides an integrated framework of cloud-hosted data resources and curated workflows to enable facile prediction of SLIs. This resource addresses two main challenges related to SLI inference: the need to wrangle and preprocess large multi-omic datasets and the availability of multiple comparable prediction approaches. SL-Cloud enables customizable computational inference of SLIs and testing of prediction approaches across multiple datasets. We anticipate that cancer researchers will find utility in this tool for discovery of SLIs to support further investigation into potential drug targets for anticancer therapies.
Insights
Synthetic lethal interactions (SLIs) offer cancer therapy potential. SL-Cloud facilitates the prediction of these interactions using cloud-based data and workflows, aiding drug target discovery.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Synthetic lethal interactions (SLIs) are genetic interactions where simultaneous gene inactivation causes cell death.
- SLIs are promising therapeutic targets in cancer, as shown by PARP inhibitors for BRCA1/2-deficient tumors.
- Predicting SLIs is challenging due to large multi-omic datasets and diverse computational approaches.
Purpose of the Study:
- To introduce SL-Cloud, a novel component of the Institute for Systems Biology Cancer Gateway in the Cloud (ISB-CGC).
- To provide an integrated framework for cloud-hosted data and curated workflows to simplify SLI prediction.
- To address challenges in SLI inference, including data preprocessing and the need for multiple prediction methods.
Main Methods:
- SL-Cloud offers customizable computational inference of SLIs.
- It allows testing of various prediction approaches across multiple datasets.
- The framework integrates cloud-hosted data resources and curated workflows.
Main Results:
- SL-Cloud provides a unified platform for SLI prediction.
- It enables researchers to process large multi-omic datasets efficiently.
- The tool facilitates the comparison and validation of different SLI prediction strategies.
Conclusions:
- SL-Cloud is a valuable resource for cancer researchers.
- It supports the discovery of novel SLIs for potential anticancer drug targets.
- The platform enhances the investigation of synthetic lethality in cancer therapy.
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Discovery: Overview
Protein-protein Interfaces

